<p>Mice were intranasally (IN) inoculated with Vero cell lysate (vehicle) or HSV-1 (10<sup>2</sup> PFU). After 4 weeks, mice received an intragastric inoculum (IG) of Vero cell lysate (vehicle) or HSV-1 (10<sup>8</sup> PFU). Mice were randomly allocated to receive 100 μL of either phosphate buffered saline (vehicle) or <i>S</i>. <i>boulardii</i> CNCM I-745 by daily oral gavage starting 4 weeks after IG viral inoculum. Animals were sacrificed 10 weeks after IG viral inoculum. n = 8 mice for each experimental group.</p
<p>(<b>A</b>) Design of mouse vaccine-challenge experiment. Mice were immunized in their right, rear...
The overall scheme for the administration of virus and antibody is described in (A). Eight-week-old ...
<p>On Day 70, naïve or live-0ΔNLS-immunized mice were challenged with 200,000 pfu per eye of HSV-2 M...
(A) WT and Cyld -/- mice were injected intravenously with HSV-1 at a dose of 5×107 pfu per mouse, an...
<p><b>(A)</b> B6-Rag or <b>(B)</b> 129-Rag mice infected with HSV1 at 10x, 32x or 100x LD<sub>50</su...
(A-C) Efficacy of virus inoculation. (A) Western blot showing the presence of ICP4 in trigeminal gan...
<p>Groups of mice (n = 10) were infected by the intravaginal route with a single dose (ranging from ...
<p>8 weeks old WT mice were infected intra-vaginally with 6.7×10<sup>4</sup> PFUs HSV-2. mIL-21 trea...
<p>HM. BALB/c mice were fed with HM (0.25 or 0.5 mg/kg) or ACV (5 mg/kg) and after 8 h of drug treat...
<p>Groups of seven mice were inoculated by the intranasal route with 10<sup>6</sup> PFU of BR-VACV B...
<p>Groups of mice were infected intracranially (A, B) or intraperitoneally (C) with the indicated do...
Mice could be significantly protected against infection with herpes simplex virus (HSV) by i.p. or i...
An experimental model of herpetic infection based on intranasal challenge of 12-day-old mice with he...
<p>(A) BALB/c mice were infected intranasal with a sub-lethal dose of IAV on day 0. Intraperitoneal ...
<p>Ten mice/group were inoculated intravaginally with 10<sup>3</sup> pfu/mouse of HSV1-LacZ, HSV1-Ta...
<p>(<b>A</b>) Design of mouse vaccine-challenge experiment. Mice were immunized in their right, rear...
The overall scheme for the administration of virus and antibody is described in (A). Eight-week-old ...
<p>On Day 70, naïve or live-0ΔNLS-immunized mice were challenged with 200,000 pfu per eye of HSV-2 M...
(A) WT and Cyld -/- mice were injected intravenously with HSV-1 at a dose of 5×107 pfu per mouse, an...
<p><b>(A)</b> B6-Rag or <b>(B)</b> 129-Rag mice infected with HSV1 at 10x, 32x or 100x LD<sub>50</su...
(A-C) Efficacy of virus inoculation. (A) Western blot showing the presence of ICP4 in trigeminal gan...
<p>Groups of mice (n = 10) were infected by the intravaginal route with a single dose (ranging from ...
<p>8 weeks old WT mice were infected intra-vaginally with 6.7×10<sup>4</sup> PFUs HSV-2. mIL-21 trea...
<p>HM. BALB/c mice were fed with HM (0.25 or 0.5 mg/kg) or ACV (5 mg/kg) and after 8 h of drug treat...
<p>Groups of seven mice were inoculated by the intranasal route with 10<sup>6</sup> PFU of BR-VACV B...
<p>Groups of mice were infected intracranially (A, B) or intraperitoneally (C) with the indicated do...
Mice could be significantly protected against infection with herpes simplex virus (HSV) by i.p. or i...
An experimental model of herpetic infection based on intranasal challenge of 12-day-old mice with he...
<p>(A) BALB/c mice were infected intranasal with a sub-lethal dose of IAV on day 0. Intraperitoneal ...
<p>Ten mice/group were inoculated intravaginally with 10<sup>3</sup> pfu/mouse of HSV1-LacZ, HSV1-Ta...
<p>(<b>A</b>) Design of mouse vaccine-challenge experiment. Mice were immunized in their right, rear...
The overall scheme for the administration of virus and antibody is described in (A). Eight-week-old ...
<p>On Day 70, naïve or live-0ΔNLS-immunized mice were challenged with 200,000 pfu per eye of HSV-2 M...